The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Yassine, Hussein N ^a   Jackson, Angela M ^b   Borges, Chad R ^c   Billheimer, Dean ^d   Koh, Hyunwook ^a   Smith, Derek ^c   Reaven, Peter ^e   Lau, Serrine S ^d   Borchers, Christoph H ^b,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e CARL T HAYDEN VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Cardiovascular disease; Diabetes; High density lipoprotein; Multi analyte panel; Multiple reaction monitoring; Proteomics

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ASSAY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; MONITORING; PROTEIN ANALYSIS; PROTEOMICS;

AGED; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PROTEOME; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY;

EID: 84892160736     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-8     Document Type: Article

References (20)

1. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, et al. J Clin Invest 2007 117 746 756 10.1172/JCI26206 17332893 (Pubitemid 46348533)
2. Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia. Hoofnagle AN, Wu M, Gosmanova AK, Becker JO, Wijsman EM, Brunzell JD, Kahn SE, Knopp RH, Lyons TJ, Heinecke JW, Arterioscler Thromb Vasc Biol 2010 30 2528 2534 10.1161/ATVBAHA.110.212894 20847305
3. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, Hafiane A, Krimbou L, Laboissiere S, Genest J, Biochim Biophys Acta 1821 2012 405 415
4. Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Green PS, Vaisar T, Pennathur S, Kulstad JJ, Moore AB, Marcovina S, Brunzell J, Knopp RH, Zhao XQ, Heinecke JW, Circulation 2008 118 1259 1267 10.1161/CIRCULATIONAHA.108.770669 18765395
5. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Anderson L, Hunter CL, Mol Cell Proteomics 2006 5 573 588 16332733
6. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, Anderson NL, Borchers CH, Mol Cell Proteomics 2009 8 1860 1877 10.1074/mcp.M800540-MCP200 19411661
7. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, et al. Nat Biotechnol 2009 27 633 641 10.1038/nbt.1546 19561596
8. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T, Clin Chem 2012 58 777 781 10.1373/clinchem.2011.173856 22307200
9. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W, N Engl J Med 2011 365 2255 2267 22085343
10. Effect of torcetrapib on the progression of coronary atherosclerosis. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM, N Engl J Med 2007 356 1304 1316 10.1056/NEJMoa070635 17387129 (Pubitemid 46513296)
11. Effects of dalcetrapib in patients with a recent acute coronary syndrome. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, et al. N Engl J Med 2012 367 2089 2099 10.1056/NEJMoa1206797 23126252
12. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. Carson RT, Vignali DA, J Immunol Methods 1999 227 41 52 10.1016/S0022-1759(99)00069-1 10485253 (Pubitemid 29408703)
13. Multiplexed immunobeadbased assay for detection of oral cancer protein biomarkers in saliva. ArellanoGarcia M, Hu S, Wang J, Henson B, Zhou H, Chia D, Wong D, Oral diseases 2008 14 705 712 10.1111/j.1601-0825.2008.01488.x 19193200
14. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Clin Immunol 2004 110 252 266 10.1016/j.clim.2003.11.017 15047203 (Pubitemid 38402005)
15. Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: Potential applications to cardiovascular disease and diabetes. Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R, Proteomics Clin Appl 2013 7 528 540 10.1002/prca.201200028 23696124
16. Lipoprotein (a). Heterogeneity and biological relevance. Scanu AM, Fless GM, J Clin Investig 1990 85 1709 10.1172/JCI114625 2140835
17. Human Apolipoprotein D Gene: Gene Sequence, Chromosome Localization, and Homology to the α2u-Globulin Superfamily. DRAYNA DT, McLEAN JW, WION KL, TRENT JM, DRABKIN HA, LAWN RM, Dna 1987 6 199 204 10.1089/dna.1987.6.199 2439269 (Pubitemid 17117191)
18. Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins. Niederkofler EE, Tubbs KA, Kiernan UA, Nedelkov D, Nelson RW, J Lipid Res 2003 44 630 639 10.1194/jlr.D200034- JLR200 12562854 (Pubitemid 37279713)
19. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. Proc JL, Kuzyk MA, Hardie DB, Yang J, Smith DS, Jackson AM, Parker CE, Borchers CH, J Proteome Res 2010 9 5422 5437 10.1021/pr100656u 20722421
20. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A, Arterioscler Thromb Vasc Biol 2009 29 870 876 10.1161/ATVBAHA.109.186031 19325143